Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 2.00 | 4315.25 | 0.0005 | -0.9771 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 1.00 | 4315.25 | 0.0002 | -0.9847 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4203.00 | 4315.25 | 0.9740 | 0.9695 | |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3514.00 | 4315.25 | 0.8143 | 0.7745 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4365.00 | 4315.25 | 1.0115 | 1.0134 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 2500.00 | 1312.79 | 2399.00 | 4315.25 | 0.5559 | 0.4207 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 2500.00 | 1312.79 | 4249.00 | 4315.25 | 0.9847 | 0.9821 |
| BT-20 | 17-AAG | 1 | uM | 7 | 2500.00 | 1312.79 | 1394.00 | 4315.25 | 0.3230 | 0.0356 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 2500.00 | 1312.79 | 4382.00 | 4315.25 | 1.0155 | 1.0180 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 1580.00 | 4315.25 | 0.3661 | 0.1140 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4545.00 | 4315.25 | 1.0532 | 1.0614 | |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 2500.00 | 1312.79 | 3401.00 | 4315.25 | 0.7881 | 0.7410 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 2500.00 | 1312.79 | 2824.00 | 4315.25 | 0.6544 | 0.5623 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4449.00 | 4315.25 | 1.0310 | 1.0359 | |
| BT-20 | Erlotinib | 10 | uM | 7 | 2500.00 | 1312.79 | 2900.00 | 4315.25 | 0.6720 | 0.5867 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4526.00 | 4315.25 | 1.0488 | 1.0563 |
| BT-20 | Lapatinib | 10 | uM | 7 | 2500.00 | 1312.79 | 1638.00 | 4315.25 | 0.3796 | 0.1376 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 2500.00 | 1312.79 | 2258.00 | 4315.25 | 0.5233 | 0.3715 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4304.00 | 4315.25 | 0.9974 | 0.9970 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 2500.00 | 1312.79 | 4472.00 | 4315.25 | 1.0363 | 1.0420 |
| BT-20 | Lapatinib | 1 | uM | 7 | 2500.00 | 1312.79 | 4059.00 | 4315.25 | 0.9406 | 0.9299 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 2500.00 | 1312.79 | 1389.00 | 4315.25 | 0.3219 | 0.0334 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 2500.00 | 1312.79 | 4417.00 | 4315.25 | 1.0236 | 1.0273 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4301.00 | 4315.25 | 0.9967 | 0.9962 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 1.00 | 4315.25 | 0.0002 | -0.9847 |